David Lee Johnson - 01 Aug 2021 Form 4/A - Amendment Insider Report for Global Blood Therapeutics, Inc.

Role
Chief Commercial Officer
Signature
/s/ Miguel Carrillo, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Aug 2021
Net transactions value
-$64,007
Form type
4/A - Amendment
Filing time
24 Sep 2021, 19:00:19 UTC
Date Of Original Report
03 Aug 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +6,770 +22% 37,039 01 Aug 2021 Direct F1
transaction GBT Common Stock Tax liability $64,007 -2,342 -6.3% $27.33 34,697 01 Aug 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -3,125 -25% $0.000000 9,375 01 Aug 2021 Common Stock 3,125 Direct F1, F3
transaction GBT Restricted Stock Units Options Exercise $0 -3,645 -17% $0.000000 18,225 01 Aug 2021 Common Stock 3,645 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 6,770 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F4 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Remarks:

This amended Form 4 is being filed solely to attach a Power of Attorney granted by the Reporting Person which was not previously attached. All other information in the original Form 4 remains the same. The original Form 4 was timely filed on August 3, 2021. Exhibit 24 - Power of Attorney